RET INHIBITOR COMBINATION THERAPY FOR TREATING CANCER

The disclosure provides a method for treating cancer, including a RET-associated cancer, comprising administering a compound of Formula I and a microtubule-targeting agent. L'invention concerne un procédé de traitement du cancer, notamment un cancer associé à RET, comprenant l'administrati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: STANCATO, Louis Frank
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator STANCATO, Louis Frank
description The disclosure provides a method for treating cancer, including a RET-associated cancer, comprising administering a compound of Formula I and a microtubule-targeting agent. L'invention concerne un procédé de traitement du cancer, notamment un cancer associé à RET, comprenant l'administration d'un composé de formule I et d'un agent de ciblage de microtubules.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022132683A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022132683A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022132683A13</originalsourceid><addsrcrecordid>eNrjZDANcg1R8PTz8HTyDPEPUnD293Xy9HMM8fT3UwjxcA1yDIhUcAOKhwS5AgX93BWcHf2cXYN4GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGRobGRmYWxo6ExcaoAk9Eomg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RET INHIBITOR COMBINATION THERAPY FOR TREATING CANCER</title><source>esp@cenet</source><creator>STANCATO, Louis Frank</creator><creatorcontrib>STANCATO, Louis Frank</creatorcontrib><description>The disclosure provides a method for treating cancer, including a RET-associated cancer, comprising administering a compound of Formula I and a microtubule-targeting agent. L'invention concerne un procédé de traitement du cancer, notamment un cancer associé à RET, comprenant l'administration d'un composé de formule I et d'un agent de ciblage de microtubules.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220623&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022132683A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220623&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022132683A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STANCATO, Louis Frank</creatorcontrib><title>RET INHIBITOR COMBINATION THERAPY FOR TREATING CANCER</title><description>The disclosure provides a method for treating cancer, including a RET-associated cancer, comprising administering a compound of Formula I and a microtubule-targeting agent. L'invention concerne un procédé de traitement du cancer, notamment un cancer associé à RET, comprenant l'administration d'un composé de formule I et d'un agent de ciblage de microtubules.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDANcg1R8PTz8HTyDPEPUnD293Xy9HMM8fT3UwjxcA1yDIhUcAOKhwS5AgX93BWcHf2cXYN4GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGRobGRmYWxo6ExcaoAk9Eomg</recordid><startdate>20220623</startdate><enddate>20220623</enddate><creator>STANCATO, Louis Frank</creator><scope>EVB</scope></search><sort><creationdate>20220623</creationdate><title>RET INHIBITOR COMBINATION THERAPY FOR TREATING CANCER</title><author>STANCATO, Louis Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022132683A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>STANCATO, Louis Frank</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STANCATO, Louis Frank</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RET INHIBITOR COMBINATION THERAPY FOR TREATING CANCER</title><date>2022-06-23</date><risdate>2022</risdate><abstract>The disclosure provides a method for treating cancer, including a RET-associated cancer, comprising administering a compound of Formula I and a microtubule-targeting agent. L'invention concerne un procédé de traitement du cancer, notamment un cancer associé à RET, comprenant l'administration d'un composé de formule I et d'un agent de ciblage de microtubules.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022132683A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title RET INHIBITOR COMBINATION THERAPY FOR TREATING CANCER
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A13%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STANCATO,%20Louis%20Frank&rft.date=2022-06-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022132683A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true